28 related articles for article (PubMed ID: 16580210)
1. Computational design and experimental discovery of an antiestrogenic peptide derived from alpha-fetoprotein.
Kirschner KN; Lexa KW; Salisburg AM; Alser KA; Joseph L; Andersen TT; Bennett JA; Jacobson HI; Shields GC
J Am Chem Soc; 2007 May; 129(19):6263-8. PubMed ID: 17441722
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical characterization of
Miyajima Y; Noguchi-Yachide T; Ochiai K; Fujii S
RSC Med Chem; 2024 Jan; 15(1):119-126. PubMed ID: 38283218
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of chroman derivatives with dual anti-breast cancer and antiepileptic activities.
Rawat P; Verma SM
Drug Des Devel Ther; 2016; 10():2779-88. PubMed ID: 27621598
[TBL] [Abstract][Full Text] [Related]
4. Discovery of thiochroman derivatives bearing a carboxy-containing side chain as orally active pure antiestrogens.
Kanbe Y; Kim MH; Nishimoto M; Ohtake Y; Tsunenari T; Taniguchi K; Ohizumi I; Kaiho S; Nabuchi Y; Kawata S; Morikawa K; Jo JC; Kwon HA; Lim HS; Kim HY
Bioorg Med Chem Lett; 2006 Aug; 16(15):4090-4. PubMed ID: 16709454
[TBL] [Abstract][Full Text] [Related]
5. Newly discovered orally active pure antiestrogens.
Kanbe Y; Kim MH; Nishimoto M; Ohtake Y; Yoneya T; Ohizumi I; Tsunenari T; Taniguchi K; Kaiho S; Nabuchi Y; Araya H; Kawata S; Morikawa K; Jo JC; Kwon HA; Lim HS; Kim HY
Bioorg Med Chem Lett; 2006 Sep; 16(18):4959-64. PubMed ID: 16806917
[TBL] [Abstract][Full Text] [Related]
6. New generation dopaminergic agents. 1. Discovery of a novel scaffold which embraces the D2 agonist pharmacophore. Structure-activity relationships of a series of 2-(aminomethyl)chromans.
Mewshaw RE; Kavanagh J; Stack G; Marquis KL; Shi X; Kagan MZ; Webb MB; Katz AH; Park A; Kang YH; Abou-Gharbia M; Scerni R; Wasik T; Cortes-Burgos L; Spangler T; Brennan JA; Piesla M; Mazandarani H; Cockett MI; Ochalski R; Coupet J; Andree TH
J Med Chem; 1997 Dec; 40(26):4235-56. PubMed ID: 9435894
[TBL] [Abstract][Full Text] [Related]
7. Nonpolar and short side chain groups at C-11beta of estradiol result in antiestrogens.
Zhang JX; Labaree DC; Hochberg RB
J Med Chem; 2005 Mar; 48(5):1428-47. PubMed ID: 15743187
[TBL] [Abstract][Full Text] [Related]
8. 2,5-Diphenylfuran-based pure antiestrogens with selectivity for the estrogen receptor alpha.
Zimmermann J; Liebl R; von Angerer E
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):57-66. PubMed ID: 15862950
[TBL] [Abstract][Full Text] [Related]
9. Discovery of thiochroman and chroman derivatives as pure antiestrogens and their structure-activity relationship.
Kanbe Y; Kim MH; Nishimoto M; Ohtake Y; Kato N; Tsunenari T; Taniguchi K; Ohizumi I; Kaiho S; Morikawa K; Jo JC; Lim HS; Kim HY
Bioorg Med Chem; 2006 Jul; 14(14):4803-19. PubMed ID: 16580210
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.
Jordan VC
J Med Chem; 2003 Mar; 46(6):883-908. PubMed ID: 12620065
[No Abstract] [Full Text] [Related]
11. Quinoids formed from estrogens and antiestrogens.
Bolton JL; Yu L; Thatcher GR
Methods Enzymol; 2004; 378():110-23. PubMed ID: 15038960
[No Abstract] [Full Text] [Related]
12. Advances in the science of estrogen receptor modulation.
Meegan MJ; Lloyd DG
Curr Med Chem; 2003 Feb; 10(3):181-210. PubMed ID: 12570707
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
